See more : BrightSpire Capital, Inc. (BRSP) Income Statement Analysis – Financial Results
Complete financial analysis of Intuitive Surgical, Inc. (ISRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intuitive Surgical, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Thai Energy Storage Technology Public Company Limited (3K-BAT.BK) Income Statement Analysis – Financial Results
- North American Construction Group Ltd. (NOA) Income Statement Analysis – Financial Results
- Nagarjuna Fertilizers and Chemicals Limited (NAGARFERT.BO) Income Statement Analysis – Financial Results
- Reliance Global Group, Inc. (RELIW) Income Statement Analysis – Financial Results
- AMREP Corporation (AXR) Income Statement Analysis – Financial Results
Intuitive Surgical, Inc. (ISRG)
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.13B | 2.70B | 2.38B | 2.13B | 2.27B | 2.18B | 1.76B | 1.41B | 1.05B | 874.92M | 600.83M | 372.68M | 227.34M | 138.80M | 91.68M | 72.02M | 51.67M | 26.62M | 10.19M | 0.00 |
| Cost of Revenue | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 934.80M | 814.30M | 806.50M | 717.90M | 670.90M | 608.50M | 483.50M | 383.00M | 301.12M | 254.14M | 186.54M | 124.85M | 73.77M | 50.81M | 47.65M | 34.58M | 28.22M | 13.28M | 7.03M | 0.00 |
| Gross Profit | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.19B | 1.89B | 1.58B | 1.41B | 1.59B | 1.57B | 1.27B | 1.03B | 751.05M | 620.78M | 414.29M | 247.84M | 153.57M | 87.99M | 44.03M | 37.44M | 23.46M | 13.35M | 3.16M | 0.00 |
| Gross Profit Ratio | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | 69.92% | 70.12% | 69.89% | 66.18% | 66.32% | 70.38% | 72.07% | 72.49% | 72.89% | 71.38% | 70.95% | 68.95% | 66.50% | 67.55% | 63.39% | 48.03% | 51.98% | 45.39% | 50.12% | 31.02% | 0.00% |
| Research & Development | 998.80M | 879.00M | 671.00M | 595.10M | 557.30M | 418.10M | 328.60M | 239.60M | 197.40M | 178.00M | 167.70M | 170.00M | 140.20M | 116.00M | 95.10M | 79.37M | 48.86M | 29.78M | 17.35M | 17.81M | 16.19M | 16.79M | 13.85M | 11.73M | 11.13M | 23.21M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 9.34M | 7.57M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.75M | 11.58M | 7.57M |
| Operating Expenses | 2.96B | 2.62B | 2.14B | 1.81B | 1.74B | 1.40B | 1.14B | 944.90M | 837.90M | 869.00M | 741.70M | 692.20M | 579.00M | 474.80M | 373.61M | 309.94M | 207.54M | 140.48M | 84.80M | 66.81M | 55.91M | 57.66M | 43.84M | 35.62M | 22.71M | 30.77M |
| Cost & Expenses | 5.36B | 4.65B | 3.89B | 3.31B | 3.10B | 2.52B | 2.07B | 1.76B | 1.64B | 1.59B | 741.70M | 1.30B | 1.06B | 857.80M | 674.73M | 564.08M | 394.09M | 265.33M | 158.57M | 117.62M | 103.56M | 92.24M | 72.06M | 48.90M | 29.74M | 30.77M |
| Interest Income | 192.10M | 29.70M | 69.30M | 157.20M | 116.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 29.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 421.80M | 380.40M | 317.00M | 282.50M | 199.70M | 120.10M | 95.00M | 88.90M | 89.50M | 74.40M | 67.30M | 57.80M | 46.50M | 40.40M | 34.58M | 25.08M | 13.03M | 35.27M | 6.73M | 7.11M | 10.63M | 4.55M | 4.71M | 4.75M | 2.24M | 0.00 |
| EBITDA | 2.17B | 1.58B | 1.82B | 1.05B | 1.37B | 1.32B | 1.16B | 1.05B | 740.00M | 619.20M | 919.80M | 935.90M | 741.30M | 595.60M | 377.44M | 335.92M | 219.77M | 107.36M | 75.50M | 21.18M | -1.25M | -15.67M | -15.67M | -17.53M | -17.31M | -30.77M |
| EBITDA Ratio | 30.45% | 25.35% | 31.89% | 24.09% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 38.39% | 36.58% | 38.27% | 33.44% | 20.21% | -1.79% | -21.70% | -30.41% | -65.42% | -169.80% | 0.00% |
| Operating Income | 1.77B | 1.21B | 1.82B | 773.60M | 1.37B | 1.20B | 1.05B | 945.20M | 740.00M | 544.80M | 852.50M | 878.10M | 694.80M | 555.20M | 377.44M | 310.84M | 206.74M | 107.36M | 68.77M | 21.18M | -11.88M | -20.22M | -20.38M | -22.28M | -19.55M | -30.77M |
| Operating Income Ratio | 24.80% | 19.47% | 31.89% | 17.75% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 35.53% | 34.41% | 28.81% | 30.25% | 15.26% | -12.96% | -28.07% | -39.45% | -83.67% | -191.81% | 0.00% |
| Total Other Income/Expenses | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M | 18.50M | 4.20M | 18.40M | 15.80M | 14.90M | 17.10M | 18.67M | 24.37M | 30.49M | 12.78M | 5.04M | 3.02M | 2.26M | 1.80M | 42.00K | -108.00K | 0.00 | 0.00 |
| Income Before Tax | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 980.80M | 758.50M | 549.00M | 870.90M | 893.90M | 709.70M | 572.30M | 396.11M | 335.20M | 237.23M | 120.14M | 73.81M | 24.20M | -9.62M | -18.42M | -20.34M | -22.39M | 0.00 | 0.00 |
| Income Before Tax Ratio | 27.50% | 25.82% | 33.10% | 27.69% | 33.54% | 34.36% | 35.04% | 36.27% | 31.81% | 25.75% | 38.45% | 41.03% | 40.39% | 40.50% | 37.65% | 38.31% | 39.48% | 32.24% | 32.47% | 17.44% | -10.50% | -25.58% | -39.36% | -84.08% | 0.00% | 0.00% |
| Income Tax Expense | 141.60M | 262.40M | 162.20M | 140.20M | 120.40M | 154.50M | 436.50M | 244.90M | 169.70M | 130.20M | 199.90M | 237.30M | 214.60M | 190.50M | 163.51M | 130.89M | 92.70M | 48.09M | -20.33M | 726.00K | -2.26M | -1.80M | -3.68M | -3.75M | -1.13M | 29.44M |
| Net Income | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 660.00M | 735.90M | 588.80M | 418.80M | 671.00M | 656.60M | 495.10M | 381.80M | 232.61M | 204.32M | 144.54M | 72.04M | 94.13M | 23.48M | -9.62M | -18.42M | -16.70M | -18.52M | -18.42M | -29.44M |
| Net Income Ratio | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | 30.29% | 21.09% | 27.21% | 24.69% | 19.65% | 29.62% | 30.14% | 28.17% | 27.02% | 22.11% | 23.35% | 24.06% | 19.33% | 41.41% | 16.91% | -10.50% | -25.58% | -32.32% | -69.57% | -180.68% | 0.00% |
| EPS | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 | 2.13 | 1.76 | 1.26 | 1.86 | 1.83 | 1.40 | 1.08 | 0.67 | 0.58 | 0.42 | 0.22 | 0.30 | 0.08 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| EPS Diluted | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 | 2.08 | 1.73 | 1.23 | 1.86 | 1.78 | 1.37 | 1.05 | 0.66 | 0.57 | 0.41 | 0.21 | 0.28 | 0.07 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| Weighted Avg Shares Out | 351.20M | 355.70M | 356.10M | 351.00M | 346.20M | 341.10M | 335.10M | 344.70M | 333.90M | 332.10M | 360.97M | 358.20M | 352.80M | 352.80M | 344.68M | 349.89M | 340.48M | 330.63M | 315.63M | 303.24M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
| Weighted Avg Shares Out (Dil) | 357.40M | 362.00M | 365.80M | 360.90M | 358.50M | 356.40M | 348.90M | 353.70M | 341.10M | 339.30M | 360.97M | 369.90M | 361.80M | 362.70M | 352.85M | 359.49M | 351.19M | 342.84M | 337.39M | 314.78M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
Intuitive Surgical's stock rises after third-quarter results beat on jump in robotic surgeries
Shares of Intuitive Surgical Inc. jumped after hours on Thursday after the company reported third-quarter results that beat Wall Street's expectations, helped by wider adoption of its robotic-surgery equipment.
Intuitive Surgical's Earnings Are On Deck. Will Its 41% Surge Remain Intact?
Intuitive Surgical stock is flirting with its 50-day line as the robotic surgery behemoth approaches its third-quarter report late Thursday.
Earnings Preview: What To Expect From Intuitive Surgical
Intuitive Surgical scheduled to report earnings after Thursday's close. The stock hit a record high of $496.48/share in 2024 and, as of this writing, it is currently trading near $474.
Small-Cap Russell Dominates Stock Market Hump Day
Many stocks in the Russell 2000 are small community banks, and we've seen big banks perform very well overall so far in Q3 earnings season.
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Intuitive Surgical Q3'24 Earnings Preview
Intuitive Surgical (NASDAQ: ISRG) will report its Q3 2024 results on Thursday, October 17. We expect the company's revenues to come in at $2 billion and adjusted earnings to be $1.60 per share, reflecting a top-line above, but earnings slightly...
Should ISRG Stock Be Part of Your Portfolio Ahead of Q3 Earnings?
Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Intuitive Surgical (ISRG) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Besides Wall Street's top -and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Earnings Calendar Spotlight On Netflix, Intuitive Surgical — And This AI Leader
AI Leader Taiwan Semiconductor is also on the earnings calendar, along with more financial stocks like American Express.
2 Soaring Growth Stocks Up 45% and 60% in 2024 to Buy Right Now
These stocks are on a winning streak, but there's always more for investors to consider than stock price.
Source: https://incomestatements.info
Category: Stock Reports